aluates Reports

$ 0.0

Automative

Global Insomnia Treatment Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-35Y96

Global Insomnia Treatment Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Insomnia Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-35Y96

Report

July 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F.Hoffman La-Roche AG

Merck& Co. Inc

Mylan N.V.

Pfizer Inc

PERNIX Therapeutics

Sanofi

Takeda Pharmaceutical Company Ltd

Teva Pharmaceutical Industries Ltd

Sumitomo Dainippon Pharma Co Ltd

Vanda Pharmaceuticals, Inc.

Merck& Co. Inc

Insomnia Treatment Drugs Market Size

The global market for Insomnia Treatment Drugs was valued at US$ 3127 million in the year 2024 and is projected to reach a revised size of US$ 3941 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Insomnia Treatment Drugs Market

Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Insomnia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Treatment Drugs.

The Insomnia Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insomnia Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Insomnia Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Insomnia Treatment Drugs Market Report

Report Metric	Details
Report Name	Insomnia Treatment Drugs Market
Accounted market size in year	US$ 3127 million
Forecasted market size in 2031	US$ 3941 million
CAGR	3.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Prescription Sleep Aids Over the Counter (OTC) Sleep Aids
Segment by Application	Hospital Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Insomnia Treatment Drugs Market growing?

Ans: The Insomnia Treatment Drugs Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Insomnia Treatment Drugs Market size in 2031?

Ans: The Insomnia Treatment Drugs Market size in 2031 will be US$ 3941 million.

Who are the main players in the Insomnia Treatment Drugs Market report?

Ans: The main players in the Insomnia Treatment Drugs Market are F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals, Inc.

What are the Application segmentation covered in the Insomnia Treatment Drugs Market report?

Ans: The Applications covered in the Insomnia Treatment Drugs Market report are Hospital, Pharmacy, Others

What are the Type segmentation covered in the Insomnia Treatment Drugs Market report?

Ans: The Types covered in the Insomnia Treatment Drugs Market report are Prescription Sleep Aids, Over the Counter (OTC) Sleep Aids

Recommended Reports

Mental Health Drugs

Sleep Disorders Devices

Other Treatment Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Insomnia Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Prescription Sleep Aids

1.2.3 Over the Counter (OTC) Sleep Aids

1.3 Market by Application

1.3.1 Global Insomnia Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Insomnia Treatment Drugs Market Perspective (2020-2031)

2.2 Global Insomnia Treatment Drugs Growth Trends by Region

2.2.1 Global Insomnia Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Insomnia Treatment Drugs Historic Market Size by Region (2020-2025)

2.2.3 Insomnia Treatment Drugs Forecasted Market Size by Region (2026-2031)

2.3 Insomnia Treatment Drugs Market Dynamics

2.3.1 Insomnia Treatment Drugs Industry Trends

2.3.2 Insomnia Treatment Drugs Market Drivers

2.3.3 Insomnia Treatment Drugs Market Challenges

2.3.4 Insomnia Treatment Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Insomnia Treatment Drugs Players by Revenue

3.1.1 Global Top Insomnia Treatment Drugs Players by Revenue (2020-2025)

3.1.2 Global Insomnia Treatment Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Insomnia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Insomnia Treatment Drugs Revenue

3.4 Global Insomnia Treatment Drugs Market Concentration Ratio

3.4.1 Global Insomnia Treatment Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Insomnia Treatment Drugs Revenue in 2024

3.5 Global Key Players of Insomnia Treatment Drugs Head office and Area Served

3.6 Global Key Players of Insomnia Treatment Drugs, Product and Application

3.7 Global Key Players of Insomnia Treatment Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Insomnia Treatment Drugs Breakdown Data by Type

4.1 Global Insomnia Treatment Drugs Historic Market Size by Type (2020-2025)

4.2 Global Insomnia Treatment Drugs Forecasted Market Size by Type (2026-2031)

5 Insomnia Treatment Drugs Breakdown Data by Application

5.1 Global Insomnia Treatment Drugs Historic Market Size by Application (2020-2025)

5.2 Global Insomnia Treatment Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Insomnia Treatment Drugs Market Size (2020-2031)

6.2 North America Insomnia Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Insomnia Treatment Drugs Market Size by Country (2020-2025)

6.4 North America Insomnia Treatment Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Insomnia Treatment Drugs Market Size (2020-2031)

7.2 Europe Insomnia Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Insomnia Treatment Drugs Market Size by Country (2020-2025)

7.4 Europe Insomnia Treatment Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Insomnia Treatment Drugs Market Size (2020-2031)

8.2 Asia-Pacific Insomnia Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Insomnia Treatment Drugs Market Size (2020-2031)

9.2 Latin America Insomnia Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Insomnia Treatment Drugs Market Size by Country (2020-2025)

9.4 Latin America Insomnia Treatment Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Insomnia Treatment Drugs Market Size (2020-2031)

10.2 Middle East & Africa Insomnia Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F.Hoffman La-Roche AG

11.1.1 F.Hoffman La-Roche AG Company Details

11.1.2 F.Hoffman La-Roche AG Business Overview

11.1.3 F.Hoffman La-Roche AG Insomnia Treatment Drugs Introduction

11.1.4 F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.1.5 F.Hoffman La-Roche AG Recent Development

11.2 Merck & Co. Inc.

11.2.1 Merck & Co. Inc. Company Details

11.2.2 Merck & Co. Inc. Business Overview

11.2.3 Merck & Co. Inc. Insomnia Treatment Drugs Introduction

11.2.4 Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.2.5 Merck & Co. Inc. Recent Development

11.3 Mylan N.V.

11.3.1 Mylan N.V. Company Details

11.3.2 Mylan N.V. Business Overview

11.3.3 Mylan N.V. Insomnia Treatment Drugs Introduction

11.3.4 Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.3.5 Mylan N.V. Recent Development

11.4 Pfizer, Inc.

11.4.1 Pfizer, Inc. Company Details

11.4.2 Pfizer, Inc. Business Overview

11.4.3 Pfizer, Inc. Insomnia Treatment Drugs Introduction

11.4.4 Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.4.5 Pfizer, Inc. Recent Development

11.5 Pernix Therapeutics

11.5.1 Pernix Therapeutics Company Details

11.5.2 Pernix Therapeutics Business Overview

11.5.3 Pernix Therapeutics Insomnia Treatment Drugs Introduction

11.5.4 Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.5.5 Pernix Therapeutics Recent Development

11.6 Sanofi S.A.

11.6.1 Sanofi S.A. Company Details

11.6.2 Sanofi S.A. Business Overview

11.6.3 Sanofi S.A. Insomnia Treatment Drugs Introduction

11.6.4 Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.6.5 Sanofi S.A. Recent Development

11.7 Takeda Pharmaceutical Company Ltd.

11.7.1 Takeda Pharmaceutical Company Ltd. Company Details

11.7.2 Takeda Pharmaceutical Company Ltd. Business Overview

11.7.3 Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Introduction

11.7.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.7.5 Takeda Pharmaceutical Company Ltd. Recent Development

11.8 Sumitomo Dainippon Pharma Co., Ltd

11.8.1 Sumitomo Dainippon Pharma Co., Ltd Company Details

11.8.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview

11.8.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Introduction

11.8.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.8.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Teva Pharmaceutical Industries Ltd. Company Details

11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.9.3 Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Introduction

11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.10 Vanda Pharmaceuticals, Inc.

11.10.1 Vanda Pharmaceuticals, Inc. Company Details

11.10.2 Vanda Pharmaceuticals, Inc. Business Overview

11.10.3 Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Introduction

11.10.4 Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2020-2025)

11.10.5 Vanda Pharmaceuticals, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

F.Hoffman La-Roche AG

Merck& Co. Inc

Mylan N.V.

Pfizer Inc

PERNIX Therapeutics

Sanofi

Takeda Pharmaceutical Company Ltd

Teva Pharmaceutical Industries Ltd

Sumitomo Dainippon Pharma Co Ltd

Vanda Pharmaceuticals, Inc.

Merck& Co. Inc

List of Tables

Table 1. Global Insomnia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Prescription Sleep Aids

Table 3. Key Players of Over the Counter (OTC) Sleep Aids

Table 4. Global Insomnia Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Insomnia Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Insomnia Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Insomnia Treatment Drugs Market Share by Region (2020-2025)

Table 8. Global Insomnia Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Insomnia Treatment Drugs Market Share by Region (2026-2031)

Table 10. Insomnia Treatment Drugs Market Trends

Table 11. Insomnia Treatment Drugs Market Drivers

Table 12. Insomnia Treatment Drugs Market Challenges

Table 13. Insomnia Treatment Drugs Market Restraints

Table 14. Global Insomnia Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Insomnia Treatment Drugs Market Share by Players (2020-2025)

Table 16. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Treatment Drugs as of 2024)

Table 17. Ranking of Global Top Insomnia Treatment Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Insomnia Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Insomnia Treatment Drugs, Headquarters and Area Served

Table 20. Global Key Players of Insomnia Treatment Drugs, Product and Application

Table 21. Global Key Players of Insomnia Treatment Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Insomnia Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Insomnia Treatment Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Insomnia Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Insomnia Treatment Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Insomnia Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Insomnia Treatment Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Insomnia Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Insomnia Treatment Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Insomnia Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Insomnia Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Insomnia Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Insomnia Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Insomnia Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Insomnia Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Insomnia Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Insomnia Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Insomnia Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Insomnia Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. F.Hoffman La-Roche AG Company Details

Table 47. F.Hoffman La-Roche AG Business Overview

Table 48. F.Hoffman La-Roche AG Insomnia Treatment Drugs Product

Table 49. F.Hoffman La-Roche AG Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 50. F.Hoffman La-Roche AG Recent Development

Table 51. Merck & Co. Inc. Company Details

Table 52. Merck & Co. Inc. Business Overview

Table 53. Merck & Co. Inc. Insomnia Treatment Drugs Product

Table 54. Merck & Co. Inc. Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 55. Merck & Co. Inc. Recent Development

Table 56. Mylan N.V. Company Details

Table 57. Mylan N.V. Business Overview

Table 58. Mylan N.V. Insomnia Treatment Drugs Product

Table 59. Mylan N.V. Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 60. Mylan N.V. Recent Development

Table 61. Pfizer, Inc. Company Details

Table 62. Pfizer, Inc. Business Overview

Table 63. Pfizer, Inc. Insomnia Treatment Drugs Product

Table 64. Pfizer, Inc. Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 65. Pfizer, Inc. Recent Development

Table 66. Pernix Therapeutics Company Details

Table 67. Pernix Therapeutics Business Overview

Table 68. Pernix Therapeutics Insomnia Treatment Drugs Product

Table 69. Pernix Therapeutics Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 70. Pernix Therapeutics Recent Development

Table 71. Sanofi S.A. Company Details

Table 72. Sanofi S.A. Business Overview

Table 73. Sanofi S.A. Insomnia Treatment Drugs Product

Table 74. Sanofi S.A. Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 75. Sanofi S.A. Recent Development

Table 76. Takeda Pharmaceutical Company Ltd. Company Details

Table 77. Takeda Pharmaceutical Company Ltd. Business Overview

Table 78. Takeda Pharmaceutical Company Ltd. Insomnia Treatment Drugs Product

Table 79. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 80. Takeda Pharmaceutical Company Ltd. Recent Development

Table 81. Sumitomo Dainippon Pharma Co., Ltd Company Details

Table 82. Sumitomo Dainippon Pharma Co., Ltd Business Overview

Table 83. Sumitomo Dainippon Pharma Co., Ltd Insomnia Treatment Drugs Product

Table 84. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 85. Sumitomo Dainippon Pharma Co., Ltd Recent Development

Table 86. Teva Pharmaceutical Industries Ltd. Company Details

Table 87. Teva Pharmaceutical Industries Ltd. Business Overview

Table 88. Teva Pharmaceutical Industries Ltd. Insomnia Treatment Drugs Product

Table 89. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 90. Teva Pharmaceutical Industries Ltd. Recent Development

Table 91. Vanda Pharmaceuticals, Inc. Company Details

Table 92. Vanda Pharmaceuticals, Inc. Business Overview

Table 93. Vanda Pharmaceuticals, Inc. Insomnia Treatment Drugs Product

Table 94. Vanda Pharmaceuticals, Inc. Revenue in Insomnia Treatment Drugs Business (2020-2025) & (US$ Million)

Table 95. Vanda Pharmaceuticals, Inc. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Insomnia Treatment Drugs Picture

Figure 2. Global Insomnia Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Insomnia Treatment Drugs Market Share by Type: 2024 VS 2031

Figure 4. Prescription Sleep Aids Features

Figure 5. Over the Counter (OTC) Sleep Aids Features

Figure 6. Global Insomnia Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Insomnia Treatment Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Pharmacy Case Studies

Figure 10. Others Case Studies

Figure 11. Insomnia Treatment Drugs Report Years Considered

Figure 12. Global Insomnia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Insomnia Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Insomnia Treatment Drugs Market Share by Region: 2024 VS 2031

Figure 15. Global Insomnia Treatment Drugs Market Share by Players in 2024

Figure 16. Global Top Insomnia Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Treatment Drugs as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Insomnia Treatment Drugs Revenue in 2024

Figure 18. North America Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Insomnia Treatment Drugs Market Share by Country (2020-2031)

Figure 20. United States Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Insomnia Treatment Drugs Market Share by Country (2020-2031)

Figure 24. Germany Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Insomnia Treatment Drugs Market Share by Region (2020-2031)

Figure 32. China Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Insomnia Treatment Drugs Market Share by Country (2020-2031)

Figure 40. Mexico Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Insomnia Treatment Drugs Market Share by Country (2020-2031)

Figure 44. Turkey Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Insomnia Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. F.Hoffman La-Roche AG Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 48. Merck & Co. Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 49. Mylan N.V. Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 50. Pfizer, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 51. Pernix Therapeutics Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 52. Sanofi S.A. Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 53. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 54. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 55. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 56. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Insomnia Treatment Drugs Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Global Sleep Apnea Therapies Market Insights Forecast to 2030

Global Antidepressants Drugs Market Insights Forecast to 2030

Global Sleep Disorder Therapies Market Research Report 2024

Global Anti snoring Treatment Market Insights Forecast to 2030

Global Cold Treatment Drug Market Insights Forecast to 2030

Global Anemia Treatment Drugs Market Insights Forecast to 2030

Global Insomnia Therapy Market Research Report 2025

Global Hypersomnia Drug Market Insights Forecast to 2030

Global Sleep Aid Software Market Insights Forecast to 2030

Global Insomnia Pharmacological Treatment Market Research Report 2025

Global Sleep Aids Market Insights Forecast to 2030

Global ADHD Medications Market Insights Forecast to 2030

Global Cold and Flu Drugs Market Insights Forecast to 2030

Global Leishmaniasis Treatment Market Insights Forecast to 2030

Global Medication Management Market Insights Forecast to 2030

Global Drugs for Pain Management Market Insights Forecast to 2030

Insomnia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circadian Rhythm Sleep Disorders Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions